| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |